Holy Stone Healthcare Pilot Plant
The Holy Stone Healthcare pilot plant, constructed in 2012, is located in Zhubei, Hsinchu Biomedical Science Park. The pilot plant will be qualified by the Taiwan FDA for PIC/s GMP, and is aimed to produce a new drug for clinical trial (IND in the USA), process and formulation development and scale-up.
 
Currently the Hsinchu plant is developing an oral IBD98-M based on our own HDD technology to treat inflammatory bowel disease (IBD).